DRMA Dermata Therapeutics
- 1.7500
- +0.0600+3.55%
Dermata Therapeutics News
Texas Instruments To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Wednesday
Maxim Group Maintains Dermata Therapeutics(DRMA.US) With Buy Rating, Announces Target Price $6
Express News | Maxim Group Maintains Buy on Dermata Therapeutics, Lowers Price Target to $6
Dermata Therapeutics Analyst Ratings
Express News | Dermata Therapeutics Share Are Trading Higher. The Company Reported Q2 Financial Results
Express News | Dermata Therapeutics Q2 EPS $(4.18) Misses $(3.79) Estimate
10-Q: Q2 2024 Earnings Report
Earnings Flash (DRMA) DERMATA THERAPEUTICS Posts Q2 Loss $-4.18
Dermata Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
Peering Into Dermata Therapeutics's Recent Short Interest
Express News | Dermata Therapeutics Shares Are Trading Over 100%: What You Need To Know
Trending Stocks Today | Nuzee Surges 273.78%
Why General Dynamics Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Nasdaq Down 2%; Alphabet Posts Upbeat Earnings
Express News | Dermata Therapeutics Shares Resume Trade
Express News | Dermata Therapeutics Shares Halted On Circuit Breaker To The Upside, Stock Now Up 180.8%
Top Premarket Gainers
Trending Stocks Today | Dermata Therapeutics Surges 129.23% Pre-Market
Why Enphase Energy Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Express News | Dermata Therapeutics Inc - Star-1 Topline Results Expected in Q1 of 2025
Analysis
Price Target
No Data
